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Deletion of endogenous Tau 
proteins is not detrimental in 
Drosophila
Sylvie Burnouf1,2, Sebastian Grönke1,2, Hrvoje Augustin3, Jacqueline Dols1,2, 
Marianna Karina Gorsky1,2, Jennifer Werner1,2, Fiona Kerr3, Nazif Alic3, Pedro Martinez3 & 
Linda Partridge1,2,3
Human Tau (hTau) is a highly soluble and natively unfolded protein that binds to microtubules within 
neurons. Its dysfunction and aggregation into insoluble paired helical filaments is involved in the 
pathogenesis of Alzheimer’s disease (AD), constituting, together with accumulated β-amyloid (Aβ) 
peptides, a hallmark of the disease. Deciphering both the loss-of-function and toxic gain-of-function 
of hTau proteins is crucial to further understand the mechanisms leading to neurodegeneration in AD. 
As the fruit fly Drosophila melanogaster expresses Tau proteins (dTau) that are homologous to hTau, 
we aimed to better comprehend dTau functions by generating a specific tau knock-out (KO) fly line 
using homologous recombination. We observed that the specific removal of endogenous dTau proteins 
did not lead to overt, macroscopic phenotypes in flies. Indeed, survival, climbing ability and neuronal 
function were unchanged in tau KO flies. In addition, we did not find any overt positive or negative 
effect of dTau removal on human Aβ-induced toxicity. Altogether, our results indicate that the absence 
of dTau proteins has no major functional impact on flies, and suggests that our tau KO strain is a 
relevant model to further investigate the role of dTau proteins in vivo, thereby giving additional insights 
into hTau functions.
Dysfunction of the neuronal microtubule-associated Tau protein is observed in several age-related neurodegener-
ative disorders including Alzheimer’s disease (AD), where the accumulation of highly post-translationally mod-
ified Tau species leads to the formation of intracellular neurofibrillary tangles and subsequent neuronal death. 
To date, no treatment for AD has been developed and approved that could efficiently halt the neurodegenerative 
process together with preventing, delaying or curing cognitive decline. Hence, many efforts are needed to further 
understand the biology and physiological functions of Tau on one hand, and the mechanisms leading to Tau 
dysfunction and toxicity on the other.
The fruit fly Drosophila melanogaster has been widely used as a powerful model organism to investigate in 
vivo the toxicity of proteins linked to neurodegenerative diseases, including AD (for reviews see1,2). Noteworthy, 
most of these models rely on ectopic expression of human transgenes. While these systems are suitable to inves-
tigate toxic gain-of-function of proteins, they present limitations regarding the study of physiological functions 
or the analysis of loss-of-function effects. Therefore, to gain some insights into the biology of human proteins, 
one approach is to discover the function of their homologue proteins in other species. Interestingly, the human 
Tau protein has a fly homologue called Drosophila Tau (dTau)3, which also displays microtubule-binding proper-
ties3,4. Some studies have focused on dTau functions using either Drosophila RNAi lines5–7 or tau hypomorphic/
deficiency lines4,5,8,9, leading to contradictory results regarding the potential detrimental or beneficial effects of 
Drosophila tau removal. While these fly lines constitute a first interesting approach to evaluate dTau functions, 
one drawback is that they can lead to off-target effects or disrupt the expression of other genes than tau.
To circumvent these problems with specificity of lowered tau expression and to further dissect the functions 
of the endogenous dTau protein, we have generated by homologous recombination a tau knock-out (KO) fly line 
that presents a specific deletion of the genetic region spanning from exon 2 (E2) to exon 6 (E6), which codes for 
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the microtubule-binding region of dTau. Using this line, we observed that the constitutive deletion of endogenous 
dTau proteins did not trigger major effects in terms of fly survival and fly climbing ability. In addition, we could 
not detect any detrimental effect of Drosophila tau removal on the transmission of nerve impulse within the 
Drosophila giant fiber system. Finally, our results show that toxic effects on fly survival related to the expression of 
human Aβ in the adult Drosophila nervous system are not mediated by dTau. Altogether, our study suggests that 
the specific deletion of Drosophila Tau proteins is neither detrimental nor beneficial for flies at the macroscopic 
level.
Results
In order to characterise fly Tau proteins, we first performed Western blot analysis on wild-type (wt) Drosophila 
heads, thoraces and abdomens (Fig. 1a). dTau proteins were particularly abundant in fly heads, with a major dTau 
isoform running at the apparent molecular weight (MW) of ± 55 kDa (arrow, Fig. 1a). Longer exposure time 
allowed the detection of a less-abundant dTau isoform displaying a higher apparent MW (± 75 kDa, arrowhead, 
lower panel of Fig. 1a). Fly thoraces also contained dTau proteins, although in lower amounts than fly heads. 
Interestingly, we also observed several dTau isoforms in extracts from fly thoraces, presenting a slightly different 
profile from head dTau isoforms. No dTau signal could be detected from fly abdomens (Fig. 1a). In addition, 
staining of dTau (green, Fig. 1b) in wt Drosophila embryos showed an enrichment of dTau proteins in the fly nerv-
ous system including the brain (Br), the ventral nerve chord (VNC) and the peripheral nervous system (PNS).
Interestingly, we observed that dTau proteins were highly phosphorylated. Indeed, following incubation of wt 
fly head extracts with a lambda phosphatase (λ PPase), we observed a shift of the apparent MW of dTau proteins 
(Fig. 1c) using an anti-total-dTau antibody. Further, we performed a two-dimensional (2D) gel electrophoresis 
analysis to evaluate the isoelectric profile of dTau proteins and better delineate the extent of dTau phosphoryla-
tion10. Interestingly, many dTau isovariants were observed upon staining with an anti-dTau antibody, suggesting 
that dTau was highly post-translationally modified (Fig. 1d). While most of dTau isovariants were found in a basic 
pH range, a few dTau spots were also detected in a very acidic pH range. To determine whether some of these 
isovariants corresponded to phosphorylated dTau species, we performed a λ PPase treatment on head protein 
Figure 1. Characterisation of the Drosophila Tau protein. (a) Western blot analysis showed an enrichment 
of dTau proteins in heads and thoraces of wild-type flies, with several isoforms being detected. The major dTau 
isoforms migrated at an apparent MW of ± 55 kDa (arrow) while a less abundant isoform, mainly detected 
following a long-time exposure, was detected at ± 75 kDa (arrowhead). No dTau signal could be detected in 
extracts from fly abdomens. The Actin control confirmed the presence of proteins in all investigated samples 
including fly abdomens. (b) Immunofluorescence on wt Drosophila embryos showed that dTau (green) was 
localised in the fly nervous system (Br: brain, VNC: ventral nerve chord, PNS: peripheral nervous system). 
DAPI (blue) was used to stain cell nuclei. (c,d) Phosphatase treatment on fly head extracts led to a shift of dTau 
apparent MW for both the 55 and 75 kDa bands (c) and to the loss of several dTau-positive spots (arrow and 
arrowheads) as observed by 2D gel electrophoresis (d) suggesting that they corresponded to phosphorylated 
dTau species. Actin is shown as a loading control (c).
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extracts prior to 2D gel electrophoresis. This treatment triggered the partial loss of dTau immunoreactivity, both 
in the basic (Fig. 1d, arrow) and the acidic (Fig. 1d, arrowheads) pH range, indicating that these spots consisted 
of phosphorylated dTau species. Altogether, these experiments highlight that dTau proteins are phosphorylated 
and enriched in the fly nervous system, similarly to human Tau proteins.
To further decipher the functions of endogenous dTau proteins in Drosophila, we performed homologous 
recombination to generate a tau knock-out (KO) line presenting a selective deletion of the E2 to E6 region of the 
tau gene (exon numbering based on FlyBase data for tau-RA transcript), hence avoiding mutation of surrounding 
genes such as rps10a and mir-1001 (Fig. 2a). Specific deletion of Drosophila tau was verified by RT-PCR (Fig. 2b), 
using primer pairs targeting E2 and E6 of tau. At the protein level, we observed no detectable signal for dTau 
in tau KO Drosophila embryos using immunofluorescence (Fig. 2c). Similarly, no signal could be detected by 
western blot for dTau in the tau KO line, despite comparable protein levels as shown using an anti-Actin anti-
body (Fig. 2d). Interestingly, while both the 55 kDa and 75 kDa dTau isoforms were absent from the tau KO line 
(Fig. 2e), we observed that flies carrying a combination of tau P-element insertion (tauEP3203, referred to as “tau 
EP”) and tau deficiency (Df(3R)MR22, referred to as “tau dfc”) alleles, still expressed the 75 kDa dTau isoform 
(“tau dfc/tau EP”, Fig. 2e, arrowhead; see Fig. 2a for insertion/deletion sites). It appeared that this was the con-
sequence of the P-element insertion in the first tau intron, as we observed an up-regulation of the 75 kDa dTau 
as compared to the 55 kDa dTau isoform in extracts from heterozygous tauEP3203 flies (“tau EP/TM6B”, Fig. 2e). 
Conversely, the 75 kDa-dTau protein was expressed at normal levels in heterozygous tau dfc flies (“tau dfc/TM6B”, 
Figure 2. Generation of a Drosophila tau KO line. (a) Simplified representation of the Drosophila tau gene 
based on Flybase data for tau-RA/RB transcripts, and the surrounding annotated genes. E1’ is indicated as an 
alternative exon that is part of the tau-RG transcript. Exons 2 to 6 of the tau gene, including the microtubule-
binding (MTB) region, were removed by homologous recombination. The insertion locus of tauEP3203 (tau EP) 
and the deleted region observed in the tau dfc (Df(3R)MR22) line are shown. (b) RT-PCR for both the tau 
gene (E2-E6) and a control gene (dilp6) were performed in wt and tau KO fly samples. No transcript could 
be observed for tau at the expected size in the tau KO line. (c) Immunofluorescence on tau KO Drosophila 
embryos showed no detectable signal for dTau (green). DAPI (blue) was used to stain cell nuclei. (d) Western 
blot analysis from heads of wt and tau KO flies showed no signal for the 55 kDa dTau band in the tau KO line. 
Actin is shown as a control for comparable protein levels. (e) Long-time exposure for dTau staining showed 
no detectable bands in the tau KO line. The tau dfc/tau EP line did not show any staining for the 55 kDa dTau 
band (arrow) but the higher 75 kDa isoform (arrowhead) was detected in this line. The relative amounts of 
dTau-75 kDa were increased compared to the dTau-55 kDa in the heterozygous tau EP/TM6B line but not in the 
heterozygous tau dfc/TM6B line. Actin is shown as a loading control. A dashed line delineates cut parts from 
the same western blot membrane and film.
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Fig. 2e). Importantly, we observed that the pattern of dTau expression in a Drosophila mutant specifically lack-
ing both tau E1 and the associated promoter region was similar to that of the tau dfc/tau EP line (“tau ∆ E1”, 
Supplementary Fig. 2a,b). Indeed, while we detected no signal for dTau corresponding to the 55 kDa isoform in 
the tau ∆ E1 fly line, the 75 kDa dTau was still expressed (Supplementary Fig. 2b).
Noteworthy, no signal for dTau was detected in tau KO flies (Fig. 2e). We therefore used this line to investigate 
the effect of knocking out tau on fly survival and fly climbing ability (Fig. 3). Interestingly, we did not observe 
any major effect of dTau removal, either on fly lifespan (Fig. 3a, p > 0.05, log-rank test) or on climbing behaviour 
(Fig. 3b, p > 0.05, two-way ANOVA).
Given that dTau is a neuronal protein, we hypothesized that its removal could impair neuronal fitness and 
function. We therefore performed electrophysiology experiments on adult Drosophila to quantitatively assess the 
functional status of the giant fiber pathway11 in tau KO compared to wt flies. To do so, following electric stimu-
lation of the giant fiber in the fly brain, we measured the time (response latency) for the electric signal to either 
reach the tergotrochanteral muscle (TTM, Fig. 4a) or the dorsal longitudinal muscle (DLM, Fig. 4b). Surprisingly, 
we did not detect any detrimental effect of dTau removal on response latencies in either branch of the circuit 
(Fig. 4). dTau removal even led to an apparent beneficial effect in 15-day-old tau KO flies, with a shorter response 
latency in the TTM, though this effect was not observed in older ages (*p < 0.05, Student’s t-test, Fig. 4a).
Given the lack of detrimental effects of dTau removal observed on fly survival, locomotion and neuronal 
function, we evaluated whether the tau KO line had developed functional compensation through up-regulated 
expression of other fly microtubule-associated proteins, i.e. futsch, which is the only known MAP1 homologue in 
flies, and ensconsin, a MAP7 homologue that is abundant in the fly nervous system. We measured mRNA levels of 
futsch (Fig. 5a) and ensconsin (Fig. 5b) during fly development (third instar larval (L3) stage) and in head extracts 
from young and old (10 and 40 days old, respectively) wt and tau KO flies, but we could not detect any significant 
up-regulation of their levels in the absence of dTau (p > 0.05, Student’s t-test, Fig. 5).
Finally, in the context of the amyloid cascade hypothesis, we investigated whether dTau removal influenced 
the toxicity induced by human Aβ in the fly. While the over-expression of human Aβ in the adult fly nervous 
system, using the inducible neuronal elavGS-Gal4 driver, was highly detrimental for fly survival (“Aβ /wt” plain 
red curve, Fig. 6a), we did not observe any significant modulation of Aβ -induced toxicity in the tau KO genetic 
background (“Aβ /tau KO”, plain blue curve, p > 0.05 vs. induced-Aβ /wt, log-rank test, Fig. 6a). Importantly, we 
controlled for Aβ transcript levels by qRT-PCR in both induced-Aβ /wt and induced-Aβ /tau KO lines and did 
not observe any difference (p > 0.05, Student’s t-test, Fig. 6b). These results therefore indicate that the removal of 
dTau did not affect Aβ -induced toxicity, suggesting that dTau proteins do not mediate Aβ -induced toxicity for 
fly survival.
Altogether, our results suggest that the complete lack of endogenous dTau proteins is not detrimental for 
Drosophila in terms of survival, locomotion or neuronal function and does not modulate the toxicity of human 
Aβ for fly lifespan.
Figure 3. Knocking out Drosophila tau did not affect fly lifespan or locomotion. (a) Survival curves of wild-
type (plain line) and tau KO (dotted line) flies were comparable (p > 0.05, log-rank test). (b) Climbing ability 
was evaluated in flies aged for 11 to 39 days. No climbing defect could be observed in tau KO flies as compared 
to wt flies (p > 0.05, two-way ANOVA).
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Discussion
Deciphering the physiological functions of the Tau protein is essential to further understand the pathophysiolog-
ical mechanisms leading to its dysfunction and aggregation in neurodegenerative disorders such as Alzheimer’s 
disease. Using a new Drosophila line specifically lacking endogenous dTau proteins, we demonstrated in the pres-
ent study that dTau removal was not detrimental for fly survival, climbing ability or neuronal function. In addi-
tion, our results indicated that the lack of endogenous dTau proteins did not modulate the toxic effects induced 
by Aβ expression in the adult fly nervous system.
Drosophila Tau and human Tau are homologous proteins that present amino acid sequence similarities and 
share functional properties, notably in terms of microtubule binding3,4. Besides this, one of hTau’s major fea-
tures is phosphorylation. Indeed, the longest hTau isoform of the central nervous system, which consists of 441 
amino acids, holds 85 putative phospho-sites (for review see12). Similarly, the 361 amino acid dTau protein (corre-
sponding to the most abundant Tau-PA/Tau-PB protein isoforms on FlyBase) contains 52 putative phospho-sites 
(32 serines, 17 threonines and 3 tyrosines), suggesting that dTau proteins might also be modified and regulated 
by phosphorylation events. In support of this hypothesis, it was previously shown that dTau proteins could be 
detected by a cross-reacting antibody raised against phosphorylated hTau at both Ser262 and Ser356 (12E8 anti-
body13), indicating that dTau proteins were phosphorylated at this epitope. In line with these observations, we 
observed, using a combination of lambda phosphatase treatment, 1D- and 2D-gel electrophoresis, that dTau 
proteins were highly phosphorylated in fly heads under physiological conditions. Understanding the specific 
effects of phosphorylation events for dTau functions, e.g. binding to microtubules, subcellular localisation or 
protein-protein interactions, will require further experiments.
While originally described as relatively simple3, the complexity of the Drosophila tau gene locus was revealed 
by more recent observations (Flybase data, summed up in Supplementary Fig. 1). Indeed, dTau has different 
promoters and is subjected to alternative splicing, leading to the production of several tau transcripts and dTau 
protein isoforms. Thirteen tau transcripts have been annotated so far, 12 of which hold the microtubule-binding 
region (MTBR) that is encoded by exons 4, 5 and 6. Importantly, one of the latter, tau-RA, encoding the 361 
amino acid Tau-PA isoform, is expressed at high levels and represents approximately 80% of all tau transcripts14. 
Western blot analysis of the recombinant Tau-PA protein revealed an apparent MW of 50–55 kDa (data not 
Figure 4. Knocking out Drosophila tau did not impair neurotransmission in the giant fiber neuronal 
system. Electrophysiological recordings were performed in 15- and 34-day-old wt and tau KO flies. Following 
stimulation of the giant fiber, response latency, the time for the electric signal to reach the TTM (a) and the 
DLM (b) was measured (*p < 0.05, Student’s t-test, n = 4–6/genotype).
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shown), suggesting that the major 55 kDa-dTau band that we observed in fly heads is constituted, at least in part, 
of the Tau-PA isoform. In addition, using the tau ∆ E1 Drosophila line specifically lacking tau exon 1 and the asso-
ciated promoter region, we did not detect the 55 kDa-dTau isoform, further supporting that this dTau isoform 
held tau exon 1. Interestingly, we observed the residual expression of a higher dTau isoform with the apparent 
MW of 75 kDa in the tau ∆ E1 fly line. Similarly, expression of this dTau isoform was observed in both tau dfc/tau 
EP and tau EP/TM6B fly lines, suggesting that this was a feature of the P-element insertion in the first tau intron. 
Noteworthy, an alternative tau promoter driving the expression of the tau-RG transcript was recently annotated 
(Flybase data, see Supplementary Fig. 1). This promoter is located downstream of both the tau sequence that is 
excised in the tau ∆ E1 mutant and of the P-element insertion in the tau EP line, suggesting that its expression 
is not blunt in those lines. Altogether, this suggests that the alternative downstream tau promoter is driving the 
expression of the bigger 75 kDa-dTau isoform, which likely corresponds to the Tau-RG protein.
To generate the tau KO Drosophila line, we specifically excised exons 2 to 6 of Drosophila tau, thereby ensur-
ing that expression of the 12 known MTBR-holding transcripts would be abolished. A small tau-RE transcript 
may still be expressed in the tau KO line, potentially leading to the production of a 10 kDa Tau-PE polypep-
tide (Supplementary Fig. 1). Though deciphering whether this isoform is normally expressed in fly neurons will 
require further experiments, the fact that this polypeptide does not contain any MTBR however suggests that it 
does not bind to microtubules.
Further, using homologous recombination to generate the tau KO line, we preserved embedded genes such as 
rps10a and mir-1001 by restricting the genetic deletion to tau sequence. Therefore, this strategy ensured the unbi-
ased analysis of dTau functions, preventing, on one hand, residual expression of some microtubule-bound dTau 
isoforms and, on the other, preserving the presence of surrounding genes, as their alteration might confound the 
interpretation of results regarding dTau functions.
The genetic fly tools so far available to investigate dTau loss-of-function are based on either P-elements inser-
tions or excisions to disrupt tau expression, or on expression of RNAi constructs to decrease tau levels. These 
models, though giving some hints with regards to dTau functions, should be considered carefully. Indeed, inser-
tion of P-elements such as tauEP3203 in the first intron of tau9 did not prevent the expression of some dTau iso-
forms (Fig. 2e) and has also been reported to alter rps10a expression (Flybase data). As for deficiency lines, 
their generation relies on the imprecise excision of P-elements. In the case of the Df(3R)MR22 (tau dfc) line, the 
recombination of tauEP3203 9 produced a deletion of 62 kb within the fly genome, which was homozygous lethal 
Figure 5. Knocking out Drosophila tau did not trigger compensatory effects in other MAPs transcript 
levels. qPCR evaluation of futsch (a) and ensconsin (b) mRNA levels was performed in third instar larvae and in 
10- and 40-day-old wt and tau KO flies. Actin5c was used for normalisation. No difference in expression could 
be detected among the lines (p > 0.05, Student’s t-test, n = 4–6 replicates/genotype).
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and affected genomic regions beyond the tau gene, spanning approximately 16 kb3. Finally, tau RNAi lines only 
partially reduce tau levels7 and might also induce off-target effects.
Therefore, we aimed to investigate the consequences of the specific removal of Drosophila Tau proteins using 
our tau KO fly line. Interestingly, we did not observe any major effect of dTau removal on fly survival, climb-
ing ability or neuronal fitness. These results are in line with previous studies investigating the consequences of 
knocking-out mouse Tau (mTau) proteins, where homozygous tau KO mice were viable and presented no overt 
phenotype15–18. It was however observed that older tau KO mice developed motor deficits including reduced 
performance on the Rotarod and altered locomotion in the open field test19,20. In contrast, tau KO flies displayed 
no overt locomotion defects throughout life as observed using a counter-current climbing system. Even though 
we cannot rule out that basal locomotion might be altered in tau KO flies, it appeared that dTau proteins did not 
regulate the locomotion of flies in response to a mild stress induced by a mechanical jolt.
Interestingly, the absence of major detrimental effects observed following tau removal occurred without any 
change in the expression of futsch and ensconsin. These two microtubule-associated proteins are enriched in the 
fly nervous system21,22 and constitute the only known fly homologues of MAP1 and MAP7, respectively. In tau KO 
mice, even though MAP1A, MAP1B and MAP2 levels were not altered in adult brains, MAP1A expression was 
increased in newborn mice, presumably to compensate for the loss of mTau15–17. In contrast, we did not observe 
any difference in the transcript levels of the fly MAP1 homologue futsch, either at the larval stage or in adult flies, 
suggesting that the absence of overt phenotypes observed following dTau removal was independent from any 
compensatory feedback loop involving futsch in flies. However, Futsch loss-of-function was shown to alter den-
dritic and axonal growth23 during fly development, suggesting that Futsch is crucial for neuronal development. 
In addition, other reports indicate that neuronal over-expression of dTau in futsch mutants could partially rescue 
some of the detrimental phenotypes induced by Futsch loss-of-function21. Further experiments will be needed 
to determine whether dTau removal exacerbates the phenotypes observed in futsch loss-of-function fly mutants.
Finally, in the context of the amyloid cascade hypothesis, we investigated whether dTau proteins mediated the 
toxicity of human Aβ in Drosophila. Many studies have highlighted beneficial effects of absence of endogenous 
mTau proteins with regards to human Aβ toxicity24–27, indicating that mTau mediated Aβ toxic effects. However, 
mTau removal was also reported to exacerbate Aβ -induced cognitive alterations in older mice28, indicating that 
additional studies are needed to understand the complexity of the interaction between mTau proteins and human 
Aβ peptides. Importantly, we did not observe any modulation of Aβ -induced toxicity in tau KO flies, their sur-
vival being similar to that of flies expressing human Aβ in a wild-type genetic background. This result suggests 
Figure 6. Knocking out Drosophila tau did not affect toxicity of human Aβ for fly lifespan. (a) Adult-onset 
expression of human Aβ in fly neurons (elavGS driver) led to a drastic reduction of fly survival in both wt (Aβ /
wt, plain red line) and tau KO (Aβ /tau KO, plain blue line) backgrounds (p > 0.05, RU-induced Aβ /wt vs. RU-
induced Aβ /tau KO, log-rank test). Non-induced controls are shown as colour-matched dotted lines. RU486 
feeding did not impair survival of the elavGS driver control lines (black and purple lines). (b) qPCR analysis of 
Aβ mRNA levels retrieved from head extracts of RU-induced Aβ /wt and Aβ /tau KO flies showed no difference 
in expression (p > 0.05, Student’s t-test, n = 4–5/genotype).
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that dTau proteins were not mediating human Aβ toxicity for fly lifespan. However, previous results have sug-
gested that dTau loss-of-function (tauEP3203/Df(3R)MR22) could reduce toxicity induced by Aβ expression in 
adult fly neurons8. Though the implication of other genes than tau cannot be firmly excluded regarding this effect 
in the latter line, one could speculate that the 75 kDa-dTau isoform, the expression of which is up-regulated in 
the tau EP/tau dfc line, displays some particular function that would be beneficial in particular condition such as 
stress conditions triggered by human Aβ expression. This aspect will deserve further investigation.
In summary, we have generated a new Drosophila tau KO line specifically lacking endogenous dTau proteins 
and avoiding potential side effects that could result from the alteration of other genes. Removal of endogenous 
dTau proteins did not lead to overt detrimental or beneficial effects on survival, climbing ability or neuronal func-
tion in Drosophila. Further investigations can be achieved using this new fly line to understand the role of dTau 
proteins and thereby give some insights into human Tau functions.
Material and Methods
Generation of the Drosophila tau KO and tau ∆E1 lines by homologous recombination. We 
used ends-out homologous recombination29 to generate two different mutant Drosophila tau alleles named tau 
∆ E1 and tau KO. The sequences for tau promoter and exon 1, and tau exons 2 to 6, respectively, were replaced by 
a whitehs marker gene (Fig. 2a and Supplementary Fig. 2a). In order to clone the tau donor constructs for homol-
ogous recombination, approximately 4 kb of the 5′ and the 3′ flanking sequences were PCR-amplified using the 
BAC clone CH321-16D24 (BACPAC Resource Center, Oakland, California, USA) as template. For the tau ∆ E1 
donor construct, primers SOL192/SOL193 and SOL298/SOL299 were used to amplify the 5′ and 3′ arms, respec-
tively. For the tau KO donor construct, primers SOL196/SOL197 and SOL198/SOL199 were used to amplify the 
5′ and 3′ arms, respectively. Subsequently, PCR products were sub-cloned into the pGX attP vector30 using the 
indicated restriction sites and were full-length sequenced. The pGX attP vector was obtained from the Drosophila 
Genomics Resource Center (Bloomington, Indiana, USA). The tau donor constructs were transformed into the 
germ line of Drosophila melanogaster by P-element-mediated germ line transformation using the Best Gene 
Drosophila Embryo Injection Service (Chino Hills, California, USA). Crosses for ends-out homologous recom-
bination were carried out according to the rapid targeting scheme31. Subsequently, the whitehs marker gene was 
genetically mapped and homologous recombination events were identified by PCR.
Primers used for the tau KO line:
SOL196: TAGCGGCCGCGACCAAGGGAAGCCAACCAAAAG (NotI)
SOL197: TAGGTACCTTAAATGGCTTCACTAATGGTCTTTGG (KpnI)
SOL198: TAGGCGCGCCATGTGTTCCCGAAGGTGTTTG (AscI)
SOL199: TACTCGAGCACGATTCCCTCCCGCAACA (XhoI)
Primers used for the tau ∆ E1 line:
SOL192: TAGGTACCGCTAACTGCCCTTTTTGGACGCTT (KpnI)
SOL193: TAGCGGCCGCGCAGATTCGTGGCAACAA (NotI)
SOL298: TAACTAGTGCATACGCCGCGTGTGCTTTAG (SpeI)
SOL299: TAGGCGCGCCTGCAACAACCCAGCGAAGAGC (AscI)
Fly stocks and maintenance. All fly stocks were kept at 25 °C on a 12:12 h light:dark cycle at constant 
humidity and fed with standard sugar/yeast/agar medium (15 g/L agar, 50 g/L sugar, 100 g/L yeast, 30 mL/L nipa-
gin and 3 mL/L propionic acid).
Human Aβ 1−42arctic (E22G mutation) bearing a secretion signal from the Drosophila necrotic gene was synthe-
sized by MWG Operon (Germany) using insect optimized codons and was cloned into the pUASTattB vector for 
insertion into the attP40 landing-site locus of the fly genome using a ϕ C31-mediated integration. Flies expressing 
one copy of the Aβ 1−42arctic gene were used for experiments. The neuron-specific Elav-GeneSwitch-Gal4 induc-
ible driver line (elavGS) was derived from the original elavGS 301.2 line32 and obtained as a generous gift from 
Dr. H. Tricoire (CNRS, France). Expression using the elavGS driver was achieved through addition of RU486 
(Mifepristone) to fly food at a final concentration of 200 μM, while food from control flies was supplemented 
with the vehicle, ethanol. All lines were backcrossed into a white Dahomey (wDah) wild-type, outbred genetic 
background for at least ten generations prior to experiments. The newly-generated tau KO and tau ∆ E1 lines 
were homozygous viable and were therefore kept as homozygous stocks. tau dfc (Df(3R)MR22; stock 9530) and 
tauEP3203 (stock 17098) lines were obtained from Bloomington Drosophila stock centre.
All experiments were carried out with female flies and at the temperature of 25 °C except electrophysiology 
recordings in Fig. 4 and lifespans in Fig. 6, which were performed at 29 °C.
Lifespan analysis. For lifespan experiments, 150 to 200 once-mated, female flies per genotype were allocated 
to lifespan vials at a density of 10 flies per vial. The number of dead flies was recorded every 2 to 3 days while flies 
were transferred to fresh food. Lifespan results are expressed as the proportion of survivors ± 95% confidence 
interval.
Climbing assay. Climbing assays were performed blindly throughout the life of flies as described before33,34. 
At least 3 replicates of 20 females flies per genotype were used for the experiments.
Generation of the anti-dTau antibody. The full-length (FL, 1.1 Kb) tau (CG31057) region was ampli-
fied from a pUAST-dtau vector (kind gift from Efthimios Skoulakis, Vari, Greece35) using the following prim-
ers: FL forward, 5′ -CACCATGGCGGATGTCCTGGAG-3′ ; FL reverse, 5′ -tgcatttcggcatTTAGCTTTGTTGA-3′ 
(lower case denotes region in pUAST vector). FL-dtau cDNA was then cloned into pENTR/D-TOPO entry 
and pDEST17 expression vectors, according to the manufacturers’ instructions (Invitrogen), and confirmed by 
sequencing. For dTau recombinant protein expression and subsequent antibody production, BL21-DE3 cells 
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(Invitrogen) were transformed with mini-prepped (Qiagen) FL-dtau cDNA, and induced by incubation with 
1 mM IPTG (Isopropyl β -D-1-thiogalactopyranoside). Recombinant proteins were purified, using a Nickel-NTA 
column, by Fast protein liquid chromatography (AktaPurifier, GE Healthcare) across a 25–400 mM imidazole 
gradient. dTau-containing fractions were TCA-precipitated and gel-purified by SDS-PAGE, after which bands 
were excised and sent for antibody production (Eurogentech). Rabbit SK6427 anti-dTau antibody was used for 
subsequent experiments.
Immunofluorescence on Drosophila embryos. This procedure was based on Kaczynski and 
Gunawardena36 with some modifications. Briefly, following removal of the chorion and fixation in a 2% formal-
dehyde solution, embryos from wt and tau KO flies were incubated for one hour in blocking solution (5% BSA 
in PBT containing 0.2% of Triton X-100) at 4 °C and subsequently incubated overnight at 4 °C with the anti-dTau 
antibody (1/1000 in PBT with 5% BSA). Alexa Fluor 488 secondary antibody was used at a dilution of 1/200 
in PBT with 5% BSA for two hours at 4 °C. Embryos were then mounted in Vectashield with DAPI mounting 
medium and visualised using a LEICA DMI4000B/DFC 340FX inverted microscope and a 10× objective.
Electrophysiology measurements. Recordings from the Giant Fiber circuit were made essentially as 
described in Allen et al.37 and Augustin et al.11 and initially described by Tanouye and Wyman38. Briefly, flies 
were anaesthetized by cooling on ice and secured in wax, ventral side down, with the wings held outwards in the 
wax. A tungsten wire (ground electrode) was placed into the abdomen, and tungsten, stimulating electrodes were 
pushed through the eyes and into the brain to deliver a 40 V pulse for 0.03 ms using an npi electronic ISO-STIM 
01D stimulator. Recordings were made from the tergotrochanteral muscle (TTM) and the contralateral dorsal 
longitudinal muscle (DLM) using glass microelectrodes (resistance: 40–60 MΩ). The electrodes were filled with 
3 M KCl and placed into the muscles through the cuticle. Responses were amplified using Axoclamp 900A micro-
electrode amplifier (Molecular Devices, USA) and the data digitized using an analogue-digital Digidata 1440A 
digitizer (Molecular Devices, USA) and Axoscope 10.5 software (Axon Instruments, USA). For response latency 
recordings, at least 3–5 single stimuli were given with a 5 s rest period between each stimulus. Recordings were 
performed blindly from at least 4 flies per genotype.
Sample preparation and Western Blotting. 10 to 20 female heads, thoraces or abdomens were homoge-
nized by sonication in 100 μL of ice-cold RIPA buffer supplemented with Complete mini without EDTA protease 
inhibitor (Roche). Protein concentration was measured using the BCA protein assay kit (Pierce) according to the 
manufacturer’s instructions. 10 μg of total proteins were supplemented with 2× LDS containing reducing agent 
(Invitrogen) and heated at 100 °C for 10 minutes prior to loading on 10% Bis-Tris Criterion gels (Biorad). Proteins 
were transferred to 0.45 μm nitrocellulose membranes (GE Healthcare) that were subsequently blocked in TNT 
buffer (Tris–HCl 15 mM pH 8, NaCl 140 mM, 0.05% Tween) with 5% non-fat dry milk for 1 h at room temper-
ature and incubated overnight at 4 °C with antibodies recognizing either full-length dTau (1/10,000) or β -Actin 
(1/200,000, Abcam). HRP-conjugated anti-mouse or anti-rabbit antibodies (1/10,000, Invitrogen) were used for 
1 h at room temperature and detection was performed using an ECL chemiluminescence kit (GE Healthcare) and 
Hyperfilms (GE Healthcare).
Phosphatase treatment. Heads of wild-type female flies were homogenized by sonication in ice-cold RIPA 
(Pierce) buffer supplemented with Complete mini without EDTA protease inhibitor (Roche). Fifty micrograms 
of total proteins were treated with Lambda Phosphatase (New England Biolabs) for 3 hours at 37 °C. Twenty 
units of enzyme per μg of total proteins were used. Samples were stored at − 80 °C until use for 1D and 2D gel 
electrophoresis.
2D gel electrophoresis. 2D gel electrophoresis experiments were performed based on previous reports39 
with some modifications. Fifty micrograms of proteins from fly heads were precipitated using the 2D clean-up kit 
(GE Healthcare). The resulting pellet was resuspended in 2D buffer (7 M urea, 2.5 M thiourea, 4% CHAPS) by son-
ication and supplemented with 0.5% IPG buffer 3–11 (GE Healthcare), 1% destreak (GE Healthcare) and traces 
of Bromophenol blue. Following overnight incubation with the protein samples in an IPG box (GE Healthcare), 
rehydrated Immobiline Drystrips (pH 3–11 NL, 11 cm) were placed into the Ettan IPGphor 3 Isoelectric Focusing 
Unit (GE Healthcare) and covered with mineral oil. The isoelectrofocalisation was performed following the man-
ufacturer’s instructions, after which the strips were incubated in equilibration buffer (6 M urea, 30% glycerol, 2% 
SDS, 50 mM Tris-HCl pH 6.8, traces of bromophenol blue) supplemented first with DTT (10 mg/mL) for 15 min 
and with iodoacetamide (50 mg/mL) for another 15 min. Strips were then placed on top of 10% Bis-Tris IPG+ 1 
Criterion gels (Biorad) for SDS-PAGE and proteins were subsequently transferred to 0.45 μm nitrocellulose mem-
branes for antibody staining.
RNA extraction and RT-PCR. Total RNA was extracted from heads of female flies (20–25 heads per rep-
licate) using a Trizol-Chloroform-based procedure (Invitrogen). One microgram of RNA was then subjected 
to cDNA synthesis using the SuperScript Vilo Mastermix (Invitrogen). PCRs were performed on 4 μL of cDNA 
using the HotStar Taq Plus polymerase (Qiagen) and the following primers: ACAATGACAGCGGCGTGGATG 
(tau E2 forward), CTTCTCACCGCCACCGGGC (tau E6 reverse), GAAAAGGAAAGGAAGCGCCG (dilp6 
control primer forward) and GGGTGTGGCTGAGTGGTGG (dilp6 control primer reverse).
Quantitative real-time PCR. Following treatment with DNAse I (Ambion), 300 ng of RNA were subjected 
to cDNA synthesis using the SuperScript Vilo Mastermix (Invitrogen). Quantitative real-time PCR was per-
formed using TaqMan primers (Applied Biosystems) in a 7900 HT real-time PCR system (Applied Biosystems). 
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Actin5c was used as a normalization control and the relative expressions of futsch, ensconsin, and Aβ were deter-
mined by the ΔΔCT method. Four to six independent biological replicates per group were analysed.
Statistical analysis. For lifespan experiments, statistical differences were assessed using the log-rank test. 
Other results are expressed as mean ± sem and differences between mean values were determined using either 
Student’s t test or two-way ANOVA, using Graphpad Prism software. p values < 0.05 were considered significant.
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